Monthly Archives: September 2019

Enforcement Update – FDA OPDP Sends Two More Letters

For those who like to keep up on the activity of the Office of Prescription Drug Promotion (OPDP) here is an update. While not shaping up to be another big year of enforcement, there has been a bit of activity … Continue reading

Posted in Warning Letters | Leave a comment

FDA OPDP Research – A Foggy Window into Future Thinking on Digital Media

When one thinks of FDA’s Office of Prescription Drug Promotion (OPDP) there is a likely tendency to think of the regulatory action letters – Warning Letters or Untitled Letters -issued by that office to pharmaceutical companies about their promotional communications. … Continue reading

Posted in New and Social Media | Tagged , , | Comments Off on FDA OPDP Research – A Foggy Window into Future Thinking on Digital Media